Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Clinical trial NCT00550927 · COMPLETED
Trial details
- NCT number
- NCT00550927
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-03-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.